Calendar Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 14:25:58 2024-12-13 EST			5-day change	1st Jan Change
102.43 ^USD	+1.17%		-0.59%	-6.00%

07:54pm	Bicycle Therapeutics Reports Updates Across Zelenectide Pevedotin Program; Shares Slump	MT
02:56pm	Merck: receives a positive opinion from the CHMP on Welireg	CF

Chart calendar Merck & Co., Inc.

83c05d1c34.Sf1eGdO0lCnu_8jmdBjBBCiCguzRvO24neOwt9hpfgM.J4o3Lb_63EfXyZGJIVelZ22y7ZqO0aDu1LrD1eksNi4HihJuvvrMSN-avw~92f8cb85f617cbbc832fef8890219d30

Upcoming events on Merck & Co., Inc.

2024-12-15	Détachement de
2025-02-04 06:30	Q4 2024 Earnings Release
2025-02-04 09:00	Q4 2024 Earnings Call
2025-04-24 06:30	Q1 2025 Earnings Release
2025-04-24 09:00	Q1 2025 Earnings Call
2025-07-29 06:30	Q2 2025 Earnings Release
2025-07-29 09:00	Q2 2025 Earnings Call
2025-10-30 06:30	Q3 2025 Earnings Release
2025-10-30 09:00	Q3 2025 Earnings Call
2026-01-28	Q4 2025 Earnings Release (Projected)
2026-04-22	Q1 2026 Earnings Release (Projected)
2026-08-03	Q2 2026 Earnings Release (Projected)
2026-11-02	Q3 2026 Earnings Release (Projected)

Past events on Merck & Co., Inc.

2024-12-05 08:00	Citi Global Healthcare Conference
2024-12-03 13:20	Evercore ISI HealthCONx Conference
2024-11-21 06:30	Jefferies London Healthcare Conference
2024-11-13 12:30	UBS Global Healthcare Conference
2024-11-11	International Papillomavirus Conference - ID #2172
2024-11-11	International Papillomavirus Conference - Poster #230
2024-11-11	International Papillomavirus Conference - Poster #209
2024-11-11	International Papillomavirus Conference - Poster #219
2024-11-11	International Papillomavirus Conference - Poster #229
2024-11-11	International Papillomavirus Conference - ID#1292
2024-11-11	International Papillomavirus Conference - ID#2397
2024-11-11	International Papillomavirus Conference - Poster #228
2024-10-31 09:00	Q3 2024 Earnings Call
2024-10-31 06:30	Q3 2024 Earnings Release
2024-10-15	IDWeek Conference - Abstract No - #1113
2024-10-15	IDWeek Conference - Abstract No - #1076
2024-10-15	IDWeek Conference - Abstract No - #1074
2024-10-15	IDWeek Conference - Abstract No - #58
2024-10-15	IDWeek Conference - Abstract No - #2305
2024-10-15	IDWeek Conference - Abstract No - #166

Past dividends on Merck & Co., Inc.

2024-09-15	Quarterly 0.77 USD
2024-06-16	Quarterly 0.77 USD
2024-03-13	Quarterly 0.77 USD
2023-12-13	Quarterly 0.77 USD
2023-09-13	Quarterly 0.73 USD
2023-06-13	Quarterly 0.73 USD
2023-03-13	Quarterly 0.73 USD
2022-12-13	Quarterly 0.73 USD
2022-09-13	Quarterly 0.69 USD
2022-06-13	Quarterly 0.69 USD
2022-03-13	Quarterly 0.69 USD
2021-12-13	Quarterly 0.69 USD
2021-09-13	Quarterly 0.65 USD
2021-06-13	Quarterly 0.65 USD
2021-03-11	Quarterly 0.65 USD
2020-12-13	Quarterly 0.65 USD
2020-09-13	Quarterly 0.61 USD
2020-06-11	Quarterly 0.61 USD
2020-03-12	Quarterly 0.61 USD

Annual results

Fiscal Period	Dezember	2021	2022	2023	2024	2025	2026
Net sales Million USD	Released Forecast Spread	48 704 48 367 0.7%	59 283 59 144 0.24%	60 115 59 938 0.3%	63 987	67 549	71 440
EBITDA Million USD	Released Forecast Spread	20 910 19 760 5.82%	26 431 24 588 7.5%	10 083 9 362 7.71%	26 919	31 570	33 945
EBIT Million USD	Released Forecast Spread	17 696 17 554 0.81%	22 522 22 363 0.71%	6 211 6 066 2.4%	23 704	28 058	30 783
Earnings before Tax (EBT) Million USD	Released Forecast Spread	13 879 12 048 15.2%	16 444 17 389 -5.44%	1 889 2 857 -33.89%	21 577	25 497	28 662
Net income Million USD	Released Forecast Spread	13 049 11 797 10.61%	14 519 14 827 -2.07%	365 1 682 -78.3%	17 770	22 088	24 668
EPS USD	Released Forecast Spread	5,14 4,70 9.39%	5,71 5,87 -2.73%	0,14 0,56 -75.16%	7,11	8,80	9,66
Announcement Date		03/02/22	02/02/23	01/02/24	-

Quarterly results

Fiscal Period	September	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4
Net sales Million USD	Released Forecast Spread	14 487 13 799 4.98%	15 035 14 450 4.05%	15 962 15 273 4.51%	14 630 14 480 1.03%	15 775 15 204 3.75%	16 112 15 844 1.69%	16 657 16 514 0.87%	15 473	16 587	17 167	17 675	17 413
EBITDA Million USD	Released Forecast Spread	5 402 5 058 6.8%	-3 485 -3 901 10.67%	7 538 6 724 12.1%	665 1 985 -66.49%	7 367 6 562 12.27%	7 177 7 367 -2.57%	5 466 5 999 -8.89%	8 606
EBIT Million USD	Released Forecast Spread	4 411 4 088 7.89%	-4 388 -4 683 6.29%	6 524 5 967 9.33%	-299 -476 37.23%	6 383 5 808 9.91%	6 659 6 519 2.14%	4 913 5 046 -2.63%	5 620	7 015	7 232
Earnings before Tax (EBT) Million USD	Released Forecast Spread	3 650 4 190 -12.89%	-5 335 -4 682 -13.95%	5 620 5 023 11.89%	-2 046 -1 249 -63.78%	5 670 5 267 7.66%	6 006 6 023 -0.29%	4 090 4 535 -9.82%	4 988
Net income Million USD	Released Forecast Spread	2 821 3 133 -9.97%	-5 975 -6 154 2.9%	4 745 4 224 12.34%	-1 226 -919 -33.43%	4 762 4 414 7.88%	5 455 4 942 10.38%	3 157 3 419 -7.66%	4 141
EPS USD	Released Forecast Spread	1,11 1,21 -8.14%	-2,35 -2,44 3.61%	1,86 1,65 12.59%	-0,48 -0,35 -37.91%	1,87 1,79 4.45%	2,14 1,93 10.86%	1,24 1,43 -13.39%	1,67
Announcement Date		27/04/23	01/08/23	26/10/23	01/02/24	25/04/24	30/07/24	31/10/24	-	-	-	-	-

Upcoming sector events for Merck & Co., Inc.

2025-01-08	HISAMITSU PHARMACEUTICAL CO., INC.: Q3 2024 Earnings Release
2025-01-12	TILRAY BRANDS, INC.: Q2 2025 Earnings Release (Projected)
2025-01-20	AARTI PHARMALABS LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-21	AARTI DRUGS LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-21	ALEMBIC PHARMACEUTICALS LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-22 06:45	JOHNSON & JOHNSON: Q4 2024 Earnings Release
2025-01-22	GLENMARK LIFE SCIENCES LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-27	GRANULES INDIA LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-28	MANKIND PHARMA LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-28	TORRENT PHARMACEUTICALS LIMITED: Q3 2025 Earnings Release (Projected)

More events

Past sector events for Merck & Co., Inc.

2024-12-10 11:45	MEDINCELL S.A.: Q2 2025 Earnings Release
2024-12-10 04:02	LOTUS PHARMACEUTICAL CO., LTD.: November 2024 Sales and Revenue Release
2024-12-09 04:04	SCINOPHARM TAIWAN, LTD.: November 2024 Sales and Revenue Release
2024-12-08 19:01	BORA PHARMACEUTICALS CO., LTD.: November 2024 Sales and Revenue Release
2024-12-04 02:06	CALIWAY BIOPHARMACEUTICALS CO., LTD.: November 2024 Sales and Revenue Release
2024-11-28	DOTTIKON ES HOLDING AG: Q2 2025 Earnings Release
2024-11-15 01:38	BAVARIAN NORDIC A/S: Q3 2024 Earnings Release
2024-11-14 23:01	CSPC PHARMACEUTICAL GROUP LTD.: Q3 2024 Earnings Release
2024-11-14 09:03	GUFIC BIOSCIENCES LIMITED: Q2 2025 Earnings Release
2024-11-14 07:00	OCULAR THERAPEUTIX, INC.: Q3 2024 Earnings Release